ELAN
Elanco Animal Health, Inc.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · US
$25.27
+2.85%Forward multiples
Based on analyst estimates
- P/E forward
- 20.87x
- P/E 2026E
- 22.21x
- P/E 2027E
- 19.87x
- P/E 2028E
- 17.64x
- P/S forward
- 2.36x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.92x
- Price / sales
- 2.52x
- Price / cash flow
- 20.46x
Enterprise value
- Enterprise value
- $16.0B
- EV / sales
- 3.19x
- EV / EBITDA
- 20.69x
- EV / EBIT
- 34.66x
- Market cap
- $12.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026